Recent laboratory and clinical studies, such as that of Nakagawa et al. and that of Subbiah et al., have revealed new targets and therapeutic treatments centered on EGF family members and their influence on lung cancer angiogenesis [48,49,50]. The gene discussed is EGF; the disease is lung carcinoma.